Skip to main content
logo
Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
255.63
+0.89 (0.35%)
Nov 6, 2026, 4:00 PM EST - Market closed

Quest Diagnostics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
3,0973,0432,8952,8062,8162,7612,6522,6212,4882,3972,3662,2882,2952,3382,3312,3332,4862,4532,6112,744
Revenue Growth (YoY)
9.98%10.21%9.16%7.06%13.18%15.19%12.09%14.55%8.41%2.52%1.50%-1.93%-7.68%-4.69%-10.72%-14.98%-10.38%-3.80%-4.01%-8.59%
Cost of Revenue
2,0552,0151,9511,8911,8651,8171,7831,7531,6721,5891,5821,5481,5391,5461,5501,5581,6101,6071,6431,714
Gross Profit
1,0421,0289449159519448698688168087847407567927817758768469681,030
Selling, General & Admin
522526498486497480463457432406436407375403430540452412416458
Amortization of Goodwill & Intangibles
3738373739393937322929272728263927272726
Other Operating Expenses
-1--2-1-2-2-11-1-11-1-2215--
Operating Expenses
558564533523537517502496463436464433403431457557480444443484
Operating Income
484464411392414427367372353372320307353361324218396402525546
Interest Expense
-67-68-65-67-69-69-72-72-58-47-49-46-41-39-37-36-37-38-37-38
Interest & Investment Income
652332579366122442-1
Earnings From Equity Investments
91047891856-886753643125
Other Non Operating Income (Expenses)
-16-29812-3-173910-3676-8-11-86
EBT Excluding Unusual Items
432427350344364381315311317331294285316337301195361359511540
Merger & Restructuring Charges
-1-4-8-46-11-31-19-5-18-13-17-40-6-7-19-65-13-12-12-10
Gain (Loss) on Sale of Investments
-2---1-1------------12-16-3
Asset Writedown
---29----------6--14----
Legal Settlements
----7-15---------------
Other Unusual Items
-4-1-418-242-2-23-4-3--5---49-8--
Pretax Income
425422338337336393294304302314274245305324282112357327483527
Income Tax Expense
998874817797596865746640687565-48177110114
Earnings From Continuing Operations
326334264256259296235236237240208205237249217116276250373413
Net Income to Company
326334264256259296235236237240208205237249217116276250373413
Minority Interest in Earnings
-14-14-12-11-14-14-15-14-11-11-14-13-12-14-15-15-20-16-18-23
Net Income
312320252245245282220222226229194192225235202101256234355390
Preferred Dividends & Other Adjustments
211-2112111-211-2111
Net Income to Common
310319251245243281219220225228193192223234201101254233354389
Net Income Growth (YoY)
27.57%13.52%14.61%11.36%8.00%23.25%13.47%14.58%0.90%-2.56%-3.98%90.10%-12.21%0.43%-43.22%-74.04%-49.50%-62.90%-24.36%-32.46%
Shares Outstanding (Basic)
110111110111112112111111112111111112112112112113116117119122
Shares Outstanding (Diluted)
112112112112113113113113113112112113114114113115118119121125
Shares Change (YoY)
-0.89%-0.89%-0.89%-0.89%-0.89%0.89%--0.88%-1.75%-0.89%-1.74%-3.39%-4.20%-6.61%-8.00%-5.60%-6.30%-10.37%-8.76%
EPS (Basic)
2.822.872.282.212.172.511.971.982.012.051.741.711.992.091.790.892.191.992.973.19
EPS (Diluted)
2.782.842.242.202.162.471.941.981.992.031.721.651.962.051.780.882.171.962.923.12
EPS Growth (YoY)
28.70%14.98%15.46%10.97%8.54%21.68%12.79%20.21%1.53%-0.98%-3.37%86.79%-9.68%4.59%-39.04%-71.67%-46.02%-60.48%-15.61%-25.62%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
44545916430741943619734125026850455102340-33187384326417337
Free Cash Flow Per Share
3.974.101.462.743.713.861.743.022.212.390.454.030.902.98-0.291.633.252.743.452.70
Dividend Per Share
0.8600.8600.8600.8000.8000.8000.8000.7500.7500.7500.7500.7100.7100.7100.7100.6600.6600.6600.6600.620
Dividend Growth (YoY)
7.50%7.50%7.50%6.67%6.67%6.67%6.67%5.63%5.63%5.63%5.63%7.58%7.58%7.58%7.58%6.45%6.45%6.45%6.45%10.71%
Gross Margin
33.65%33.78%32.61%32.61%33.77%34.19%32.77%33.12%32.80%33.71%33.14%32.34%32.94%33.88%33.51%33.22%35.24%34.49%37.07%37.54%
Operating Margin
15.63%15.25%14.20%13.97%14.70%15.47%13.84%14.19%14.19%15.52%13.53%13.42%15.38%15.44%13.90%9.34%15.93%16.39%20.11%19.90%
Profit Margin
10.01%10.48%8.67%8.73%8.63%10.18%8.26%8.39%9.04%9.51%8.16%8.39%9.72%10.01%8.62%4.33%10.22%9.50%13.56%14.18%
Free Cash Flow Margin
14.37%15.08%5.67%10.94%14.88%15.79%7.43%13.01%10.05%11.18%2.11%19.89%4.44%14.54%-1.42%8.02%15.45%13.29%15.97%12.28%
EBITDA
631610558537556570507507478489436416464473431334504509631652
EBITDA Margin
20.38%20.05%19.28%19.14%19.74%20.64%19.12%19.34%19.21%20.40%18.43%18.18%20.22%20.23%18.49%14.32%20.27%20.75%24.17%23.76%
D&A For EBITDA
147146147145142143140135125117116109111112107116108107106106
EBIT
484464411392414427367372353372320307353361324218396402525546
EBIT Margin
15.63%15.25%14.20%13.97%14.70%15.47%13.84%14.19%14.19%15.52%13.53%13.42%15.38%15.44%13.90%9.34%15.93%16.39%20.11%19.90%
Effective Tax Rate
23.29%20.85%21.89%24.04%22.92%24.68%20.07%22.37%21.52%23.57%24.09%16.33%22.30%23.15%23.05%-22.69%23.55%22.77%21.63%
SEC Filings: 10-K · 10-Q